Sue Ward

3.9k total citations · 1 hit paper
70 papers, 2.3k citations indexed

About

Sue Ward is a scholar working on Economics and Econometrics, Oncology and Cancer Research. According to data from OpenAlex, Sue Ward has authored 70 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Economics and Econometrics, 24 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Sue Ward's work include Health Systems, Economic Evaluations, Quality of Life (25 papers), Breast Cancer Treatment Studies (19 papers) and Global Cancer Incidence and Screening (13 papers). Sue Ward is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (25 papers), Breast Cancer Treatment Studies (19 papers) and Global Cancer Incidence and Screening (13 papers). Sue Ward collaborates with scholars based in United Kingdom, New Zealand and United States. Sue Ward's co-authors include Abdullah Pandor, Roberta Ara, Lynda Wyld, Daniel Hind, Nick Payne, M Lloyd Jones, W W Yeo, M Holmes, Eva Kaltenthaler and S Harnan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Cancer.

In The Last Decade

Sue Ward

64 papers receiving 2.2k citations

Hit Papers

A systematic review and e... 2007 2026 2013 2019 2007 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A systematic review and economic evaluation of statins for the prevention of coronary events
    2007 452 citations Sue Ward, Roberta Ara et al. Health Technology Assessment profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sue Ward 589 523 522 420 277 70 2.3k
Paul Abrahamse 447 0.8× 663 1.3× 824 1.6× 504 1.2× 337 1.2× 86 2.4k
Heather T. Gold 302 0.5× 204 0.4× 570 1.1× 522 1.2× 290 1.0× 104 2.0k
Cynthia Owusu 609 1.0× 452 0.9× 1.6k 3.1× 287 0.7× 501 1.8× 92 3.5k
Johanneke E.A. Portielje 280 0.5× 745 1.4× 1.7k 3.2× 430 1.0× 249 0.9× 144 3.4k
Ingolf Griebsch 283 0.5× 297 0.6× 546 1.0× 192 0.5× 123 0.4× 42 2.2k
Kojiro Shimozuma 493 0.8× 450 0.9× 1.4k 2.7× 621 1.5× 200 0.7× 148 3.1k
Jessica K. Paulus 259 0.4× 174 0.3× 547 1.0× 318 0.8× 186 0.7× 70 2.5k
Aurélien Belot 365 0.6× 330 0.6× 1.4k 2.6× 513 1.2× 232 0.8× 107 3.0k
Michaela A. Dinan 271 0.5× 427 0.8× 969 1.9× 938 2.2× 506 1.8× 118 3.3k
Christopher J. Johnson 265 0.4× 367 0.7× 1.3k 2.5× 281 0.7× 223 0.8× 41 2.7k

Countries citing papers authored by Sue Ward

Since Specialization
Citations

This map shows the geographic impact of Sue Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Ward more than expected).

Fields of papers citing papers by Sue Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Ward. The network helps show where Sue Ward may publish in the future.

Co-authorship network of co-authors of Sue Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Ward. A scholar is included among the top collaborators of Sue Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Ward. Sue Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Alshreef, Abualbishr, Bryony Dawkins, Sue Ward, et al.. (2019). Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa. Value in Health Regional Issues. 19. 65–74. 11 indexed citations
3.
Ward, Sue, Geoffrey R. Holmes, Alistair Ring, et al.. (2019). Adjuvant Chemotherapy for Breast Cancer in Older Women: An Analysis of Retrospective English Cancer Registration Data. Clinical Oncology. 31(7). 444–452. 17 indexed citations
4.
Alshreef, Abualbishr, Bryony Dawkins, Sue Ward, et al.. (2018). Assessing the Appropriateness of Existing Model Adaptation Methods for Low and Middle-Income Countries. Value in Health. 21. S8–S8. 2 indexed citations
5.
Richards, Paul, Sue Ward, Jenna Morgan, et al.. (2016). The use of surgery in the treatment of ER+ early stage breast cancer in England: Variation by time, age and patient characteristics. European Journal of Surgical Oncology. 42(4). 489–496. 21 indexed citations
6.
Ward, Sue. (2013). Atlas of Pain Management Injection Techniques. British Journal of Anaesthesia. 111(3). 519–520. 2 indexed citations
7.
Ara, Roberta, Hasan Basarir, & Sue Ward. (2012). Principles of health economic evaluations of lipid-lowering strategies. Current Opinion in Lipidology. 23(4). 271–281. 4 indexed citations
8.
9.
Peasgood, Tessa, Sue Ward, & John Brazier. (2011). PCN149 Health State Utility Values in Breast Cancer: A Review and Meta-Analysis. Value in Health. 14(7). A462–A462. 2 indexed citations
10.
Meng, Yang, Sue Ward, Katy Cooper, S Harnan, & Lynda Wyld. (2011). PMD49 The Potential Role of Magnetic Resonance Imaging (MRI) in Axillary Node Assessment of Early Breast Cancer: An Economic Evaluation. Value in Health. 14(7). A253–A253. 1 indexed citations
11.
Turner, David, James Raftery, Keith Cooper, et al.. (2011). The CHD challenge: Comparing four cost-effectiveness models. Value in Health. 14(1). 53–60. 6 indexed citations
12.
Ward, Sue, Hazel Pilgrim, & Daniel Hind. (2009). Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal. Health Technology Assessment. 13(Suppl 1). 1–6. 19 indexed citations
13.
Bansback, Nick, Roberta Ara, Sue Ward, Aslam H. Anis, & Hyon K. Choi. (2009). Statin Therapy in Rheumatoid Arthritis. PharmacoEconomics. 27(1). 25–37. 22 indexed citations
14.
Hind, Daniel, Sue Ward, Enrico De Nigris, et al.. (2007). Hormonal therapies for early breast cancer: systematic review and economic evaluation. Health Technology Assessment. 11(26). iii–iv, ix. 64 indexed citations
15.
Ward, Sue, et al.. (2006). The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer. British Journal of Cancer. 95(1). 27–34. 36 indexed citations
16.
Warren, Emma, Sue Ward, Adam Gordois, & Paul Scuffham. (2004). Cost-utility analysis of imatinib mesylate for the treatment ofchronic myelogenous leukemia in the chronic phase. Clinical Therapeutics. 26(11). 1924–1933. 24 indexed citations
17.
Gordois, Adam, Paul Scuffham, Emma Warren, & Sue Ward. (2003). Cost–utility analysis of imatinib mesilate for the treatment of advanced stage chronic myeloid leukaemia. British Journal of Cancer. 89(4). 634–640. 27 indexed citations
18.
Ward, Sue. (2001). Interview. The Art Book. 8(3). 29–30. 1 indexed citations
19.
Ebrahim, Shahul H., George Davey Smith, Candy McCabe, et al.. (1998). Cholesterol and coronary heart disease: screening and treatment. BMJ Quality & Safety. 7(4). 232–239. 45 indexed citations
20.
Nimgaonkar, V.L., et al.. (1997). Fertility in schizophrenia: results from a contemporary US cohort. Acta Psychiatrica Scandinavica. 95(5). 364–369. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Abrahamse Breakdown of academic impact, for papers by Heather T. Gold Breakdown of academic impact, for papers by Cynthia Owusu Breakdown of academic impact, for papers by Johanneke E.A. Portielje Breakdown of academic impact, for papers by Ingolf Griebsch Breakdown of academic impact, for papers by Kojiro Shimozuma Breakdown of academic impact, for papers by Jessica K. Paulus Breakdown of academic impact, for papers by Aurélien Belot Breakdown of academic impact, for papers by Michaela A. Dinan Breakdown of academic impact, for papers by Christopher J. Johnson
Rankless by CCL
2026